Total Funding
33
46
Total FundingPost-IPO Debt raised
Growth Score
-7 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
60306
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Clive Page: Co-Founder- Mahendra Shah: Non-Executive DirectorPast Role: Vivo Capital, Managing Director
About the Company
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough.
The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders.
Verona
Pharma was established in 2005 by Clive Page in London, England.
